Proposta De Métrica Do Nível De Capacidade Tecnológica Das Empresas Farmacêuticas Brasileiras

Moreira, Carlos Alexandre Guimarães; Pitassi, Claudio

doi:10.5773/rai.v10i4.1170

Cited by 3 publications

(2 citation statements)

References 27 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The tables' conceptual basis and the suitability of the TC metric evaluation were based on studies performed by Figueiredo (2009), following the models of Lall (1992) and Bell and Pavitt (1995). Although Figueiredo worked with more levels, for the reasons stated in Baginski et al (2017) and Moreira and Pitassi (2013), we decided to adopt five levels of innovation: frontier, intermediate, basic, advanced and routine basic.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Technological capability of doping control laboratories: a metric proposal

Pitassi

Lacerda

2018

International Journal of Sport Policy and Politics

Self Cite

View full text Add to dashboard Cite

The use of increasingly advanced doping techniques in sports requires constant investments in new detection processes and technologies, forcing doping control laboratories to develop their innovative capability. Although WADA considers that all accredited labs should have equal quality, sports scientists point to the huge economic and cultural differences between emerging and developed countries. This article is in line with other studies that: (1) consider doping to be a biomedical technology that needs to be analysed under the lens of innovation theory; and (2) advocate the need to redesign antidrug policies to overcome the present limitations. This paper's main objective is to present a technological capability (TC) metric for anti-doping labs that can guide their technological strategy, helping them perform a more significant role in redesigning antidrug policy. The secondary objective is to report the testing of the metric at the Brazilian Doping Control Laboratory (LBCD). The construction of the analytical framework followed the recommendations for qualitative metrics. The main result was the TC metric, formulated with input from experts on doping control. Interviews revealed that the proposed metric could help laboratories better manage their R&D processes, including drug testing. The collected evidence suggests that a global network approach, including WADA requirements that consider countries' economic realities, are crucial to guide investments and prevent drug control labs from prioritising short-term profits over steady investments in R&D.

show abstract

Section: Methodsmentioning

confidence: 99%

“…Other contributions to the qualitative interpretation of the information obtained during the exploratory research were supported by Denzin and Lincoln (2000). Planning was based on the steps proposed by Baginski et al (2017) and Moreira and Pitassi (2013):…”

Section: Methodsmentioning

confidence: 99%

Technological capability of doping control laboratories: a metric proposal

Pitassi

Lacerda

2018

International Journal of Sport Policy and Politics

Self Cite

View full text Add to dashboard Cite

show abstract

Technological capability in the Brazilian naval industry: a metric for offshore support vessels

Baginski

Pitassi

Barbosa

2017

RAI Revista de Administração e Inovação

View full text Add to dashboard Cite

A Rede Brasileira de Produção Pública de Medicamentos na perspectiva da gestão de cadeias de suprimentos: o papel das TIC

et al. 2015

Self Cite

View full text Add to dashboard Cite

A indústria farmacêutica configura-se como um oligopólio, com produtos diferenciados em segmentos de classes terapêuticas específicas. As grandes farmacêuticas globais concentram seus esforços de pesquisa e de comercialização nas doenças degenerativas, que trazem maior retorno financeiro. No Brasil, destaca-se a presença de um conjunto de laboratórios públicos, os quais compõem a Rede Brasileira de Produção Pública de Medicamentos (RBPPM), voltados para as necessidades do Sistema Único de Saúde (SUS), em grande parte negligenciadas pelas Big Pharmas. O objetivo deste estudo é investigar o uso pelos laboratórios farmacêuticos oficiais brasileiros das contribuições derivadas das tecnologias da informação e comunicação (TIC), no sentido da integração da cadeia de suprimentos da RBPPM. Em sua primeira fase, a pesquisa de campo foi realizada por meio de uma abordagem quantitativa em todos os laboratórios oficiais afiliados à Associação de Laboratórios Farmacêuticos Oficiais Brasileiros (Alfob). Essa análise permitiu levantar questões que foram aprofundadas por meio da abordagem qualitativa em três laboratórios selecionados da fase anterior. As evidências coletadas permitem concluir que os objetivos descritos na criação da RBPPM, cujo alcance poderia ser facilitado pela adoção dos atributos da GCS pela rede capitaneada pelo Ministério da Saúde, ainda são inci-

show abstract

Proposta De Métrica Do Nível De Capacidade Tecnológica Das Empresas Farmacêuticas Brasileiras

Cited by 3 publications

References 27 publications

Technological capability of doping control laboratories: a metric proposal

Technological capability of doping control laboratories: a metric proposal

Technological capability in the Brazilian naval industry: a metric for offshore support vessels

A Rede Brasileira de Produção Pública de Medicamentos na perspectiva da gestão de cadeias de suprimentos: o papel das TIC

Contact Info

Product

Resources

About